drugset / Trial / NCT03768869

Fever and Neutropenia in Pediatric Oncology Patients

NCT03768869

Phase 3 Withdrawn University of Colorado, Denver
RandomizedParallel-groupOpen-labelSupportive care

Summary

It is possible to distinguish between pediatric oncology patients who are at high or low risk for serious infection during periods of fever and treatment related neutropenia based on clinical parameters. Patients with low risk can be safely treated as outpatients primarily using oral antibiotics. It is possible to improve methods of risk stratification through the addition of genomic and proteomic factors.

Timeline

Start
2006-02
Primary completion
2009-04-03
Completion
2009-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule Intravenous

Indications